We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: cardiovascular risk
MedXY News
EnglishTag

cardiovascular risk

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Invisible Invaders: How Microplastics May Accelerate Atherosclerosis — and Why Men Could Be at Greater Risk
Cardiologyatherosclerosiscardiovascular risk

Invisible Invaders: How Microplastics May Accelerate Atherosclerosis — and Why Men Could Be at Greater Risk

By MedXY|Nov 25, 2025

New animal research links oral microplastic exposure to dramatic increases in arterial plaque—especially in males—by injuring endothelial cells and provoking inflammation and oxidative stress.

Global CKD Now Affects 788 Million Adults (1990–2023): Rising Prevalence, Growing Mortality, and a Major Cardiovascular Risk
Nephrologycardiovascular riskchronic kidney disease

Global CKD Now Affects 788 Million Adults (1990–2023): Rising Prevalence, Growing Mortality, and a Major Cardiovascular Risk

By MedXY|Nov 11, 2025

The GBD 2023 analysis estimates 788 million adults living with chronic kidney disease in 2023, rising since 1990, with CKD a top-10 cause of death and a major contributor to cardiovascular mortality. Urgent action on screening, prevention,

Even a Few Days of 4,000+ Steps Lowers Mortality and CVD Risk in Older Women — More Steps Still Better
Cardiologycardiovascular riskolder women

Even a Few Days of 4,000+ Steps Lowers Mortality and CVD Risk in Older Women — More Steps Still Better

By MedXY|Nov 3, 2025

In >13,000 older women followed ≈11 years, achieving ≥4,000 steps on as little as 1–2 days/week was linked to lower all‑cause mortality and CVD; higher daily step thresholds produced additional benefit, but associations were driven large

Aspirin Use in Chronic Coronary Syndrome Patients on Oral Anticoagulation: Balancing Risks and Benefits
CardiologyAspirincardiovascular risk

Aspirin Use in Chronic Coronary Syndrome Patients on Oral Anticoagulation: Balancing Risks and Benefits

By MedXY|Oct 31, 2025

A randomized trial revealed that adding aspirin to oral anticoagulation in chronic coronary syndrome patients increases adverse cardiovascular events, mortality, and major bleeding, challenging conventional dual therapy approaches.

Impact of Diabetes on the Triglyceride-Glucose Index and Cardiovascular Outcomes in Coronary Heart Disease: A Comprehensive Meta-Analysis
Cardiologycardiovascular riskCoronary heart disease

Impact of Diabetes on the Triglyceride-Glucose Index and Cardiovascular Outcomes in Coronary Heart Disease: A Comprehensive Meta-Analysis

By MedXY|Oct 19, 2025

This meta-analysis of 36 cohort studies shows that higher triglyceride-glucose index levels predict increased risk of major adverse cardiovascular events in coronary heart disease patients, with differential effects observed by diabetes sta

Comparing the PREVENT and PCE Models for 10-Year ASCVD Risk Prediction: Insights from a Large Real-World Cohort
Cardiologycardiovascular riskstatin therapy

Comparing the PREVENT and PCE Models for 10-Year ASCVD Risk Prediction: Insights from a Large Real-World Cohort

By MedXY|Oct 8, 2025

This review evaluates PREVENT versus PCE models for estimating 10-year ASCVD risk focusing on accuracy in patients with and without statin therapy, highlighting implications for personalized prevention.

Long-Term Outcomes of the DASH Intervention in Nonobstructive Coronary Artery Disease: Follow-Up of the DISCO-CT Study
Cardiologycardiovascular riskcoronary artery disease

Long-Term Outcomes of the DASH Intervention in Nonobstructive Coronary Artery Disease: Follow-Up of the DISCO-CT Study

By MedXY|Oct 8, 2025

A one-year DASH diet intervention led to sustained suppression of proatherogenic chemokine CXCL4 and fewer major cardiovascular events over six years despite reduced adherence and partial loss of initial benefits in nonobstructive CAD patie

The Hidden Vascular Assassin: How Homocysteine Independently Accelerates Atherosclerosis
Medical Newsatherosclerosiscardiovascular risk

The Hidden Vascular Assassin: How Homocysteine Independently Accelerates Atherosclerosis

By MedXY|Sep 14, 2025

Beyond cholesterol and blood pressure, homocysteine silently hardens arteries, driving cardiovascular disease progression independently—latest research reveals its biomechanical impact and prevention strategies.

CT Angiography Enhances Lifestyle and Prevention Uptake in Cardiovascular Risk Management: Insights from SCOT-HEART 2 Substudy
Cardiologycardiovascular riskCT Angiography

CT Angiography Enhances Lifestyle and Prevention Uptake in Cardiovascular Risk Management: Insights from SCOT-HEART 2 Substudy

By MedXY|Oct 7, 2025

A nested substudy from SCOT-HEART 2 reveals coronary CT angiography modestly improves healthy lifestyle adherence, preventive therapy acceptance, and risk factor modification compared to traditional cardiovascular risk scoring in asymptomat

Preoperative Cardiovascular Risk Does Not Alter Outcomes of Renin-Angiotensin System Inhibitor Use Before Major Noncardiac Surgery: Insights from a Secondary Analysis of the STOP-or-NOT Trial
Cardiologycardiovascular risknoncardiac surgery

Preoperative Cardiovascular Risk Does Not Alter Outcomes of Renin-Angiotensin System Inhibitor Use Before Major Noncardiac Surgery: Insights from a Secondary Analysis of the STOP-or-NOT Trial

By MedXY|Oct 7, 2025

A secondary analysis of the STOP-or-NOT trial shows that preoperative cardiovascular risk stratification does not impact postoperative outcomes related to continuing or discontinuing renin-angiotensin system inhibitors before major noncardi

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes
Cardiologyblood pressurecardiovascular risk

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

By MedXY|Oct 7, 2025

A randomized trial in China shows that a 12-month mobile message-based intervention modestly improves HbA1c and systolic blood pressure in patients with uncontrolled type 2 diabetes, supporting mHealth strategies to manage cardiovascular ri

Obicetrapib: A Promising Advance in LDL Cholesterol Lowering for High Cardiovascular Risk Patients
Cardiologycardiovascular riskCETP inhibitor

Obicetrapib: A Promising Advance in LDL Cholesterol Lowering for High Cardiovascular Risk Patients

By MedXY|Oct 6, 2025

Obicetrapib significantly reduces LDL cholesterol by nearly 30% in high-risk cardiovascular patients on maximal lipid therapy, with a safety profile comparable to placebo, representing a potential novel agent in managing familial hyperchole

Interleukin-17 Inhibitors and Cardiovascular Risk: Evaluating Early Major Adverse Cardiovascular Events
Allergy & Immunologycardiovascular riskmajor adverse cardiovascular events

Interleukin-17 Inhibitors and Cardiovascular Risk: Evaluating Early Major Adverse Cardiovascular Events

By MedXY|Oct 6, 2025

A national database study finds no significant increase in early major adverse cardiovascular events (MACEs) after starting IL-17 inhibitors in psoriasis and related diseases, although a modest risk cannot be excluded.

Lower High Blood Lipids Risk: Avoid Common Pitfalls and Embrace 4 Healthy Habits
Cardiologycardiovascular riskcholesterol

Lower High Blood Lipids Risk: Avoid Common Pitfalls and Embrace 4 Healthy Habits

By MedXY|Oct 6, 2025

High blood lipids impact over 300 million people in China, often silently increasing cardiovascular risk. Learn to avoid common misconceptions and adopt four scientifically backed habits to improve your blood lipid profile and heart health.

Intermittent Fasting: Benefits, Risks, and What Recent Research Reveals
Family Medicine & Nutritioncardiovascular riskdiet

Intermittent Fasting: Benefits, Risks, and What Recent Research Reveals

By MedXY|Oct 5, 2025

Intermittent fasting has gained popularity for its metabolic and weight-loss benefits, but new research links short eating windows to increased cardiovascular risks, urging caution and personalized approaches.

Is More Sleep Better for Cardiovascular Health? Unveiling Risks of Long Sleep Duration and the Protective Role of the Mediterranean Diet
Cardiologycardiovascular riskCoronary heart disease

Is More Sleep Better for Cardiovascular Health? Unveiling Risks of Long Sleep Duration and the Protective Role of the Mediterranean Diet

By MedXY|Oct 5, 2025

Long sleep duration is linked to increased cardiovascular events in coronary heart disease patients, but adherence to a Mediterranean diet may mitigate these risks, emphasizing sleep’s impact on heart health.

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial
Cardiologycardiovascular riskmonocytes

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial

By MedXY|Oct 5, 2025

The TRAVERSE trial reveals that testosterone replacement therapy elevates neutrophil and monocyte counts in hypogonadal men, correlating with increased venous thromboembolism and cardiovascular event risk, underscoring the need to monitor t

Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial
Cardiologycardiovascular riske-cigarettes

Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial

By MedXY|Oct 5, 2025

This review synthesizes trial evidence showing that nicotine-containing e-cigarettes modestly improve lipid profiles but cause no significant changes in lung function or other cardiovascular markers compared to cigarette substitutes in smok

Decoding 10-Year Cardiovascular Risk in Ethiopia: The Impact of Individual and Community Factors
Cardiologycardiovascular riskPhysical Activity

Decoding 10-Year Cardiovascular Risk in Ethiopia: The Impact of Individual and Community Factors

By MedXY|Oct 4, 2025

A population-based study in Ethiopia reveals 7.3% of adults aged 40-69 face a 10-year cardiovascular disease risk ≥10%, influenced by urban residence, education, physical activity, employment status, and climate factors.

Recent Advances in Cinnamon and Its Extracts: Clinical Applications and Therapeutic Potentials Across Metabolic, Cardiovascular, Cognitive, and Infectious Diseases
Cardiologycardiovascular riskCinnamon

Recent Advances in Cinnamon and Its Extracts: Clinical Applications and Therapeutic Potentials Across Metabolic, Cardiovascular, Cognitive, and Infectious Diseases

By MedXY|Oct 4, 2025

A decade of research highlights cinnamon’s benefits in glycemic control, lipid modulation, anti-inflammatory effects, cognitive enhancement, and antimicrobial activity, supporting its adjunctive clinical use and revealing promising th

Prev
5 / 6
1…3456
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities